News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Medicare meeting about Optune! Tune in this Wednesday March 6, 2019

Al's Comment:

 On a different issue, a few years ago, the medical director of Medicare told me that we will never get what we want from Medicare because the brain tumor community is not organized enough to apply pressure.  We have to show them that is no longer true.  We finally have a big step forward in the treatment of brain tumors and Medicare doesn't want to pay for it.   This is the most important advocacy issue we face now.   Trying to get additional funding for research is futile if we lose this battle because any new treatments will be expensive and if Medicare doesn't pay we won't have access anyway.

Posted on: 02/27/2019

Medicare meeting about Optune!

The meeting is on the question of should Medicare cover Optune for brain tumor patients.  I know that sounds obvious but this might not go the way we want it to go. We need to show Medicare that we care about this issue.  For starters, everyone should watch this video on Wednesday Morning 9am March 6, 2019.

It is the first half of the meeting. I do not know where the second half will be shown - ask that question in the morning session!

After the meeting, no matter what happens, we all will need to send letters to comment on it.  I will give suggestions after the meeting.


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557